Prostate-Specific Antigen Concept

subject area of

• 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice  Journal Articles
• ¹⁸F-DCFPyL PET/CT in Men with Prostate Cancer  Journal Articles
• A Large Number of Fresh Samples and a Wide Range of Total Prostate-Specific Antigen (tPSA) Concentrations Is Important to Detect Differences in PSA Methods  Journal Articles
• A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer  Journal Articles
• A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy  Journal Articles
• A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a  Conferences
• A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer  Journal Articles
• A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer  Journal Articles
• A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer  Journal Articles
• A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer  Journal Articles
• A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer  Journal Articles
• A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer  Journal Articles
• A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer  Journal Articles
• A stochastic approach to risk management for prostate cancer patients on active surveillance  Journal Articles
• Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial  Journal Articles
• Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial  Journal Articles
• Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial  Journal Articles
• Adjuvant radiation therapy, androgen deprivation, and docetaxel for high‐risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621  Journal Articles
• Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes  Journal Articles
• An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis  Journal Articles
• Assessing the necessity of including a crossover period with dual reporting when changing total prostate-specific antigen methods  Journal Articles
• Assessment of biochemical recurrence of prostate cancer (Review)  Journal Articles
• Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel  Journal Articles
• Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor  Journal Articles
• Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601  Journal Articles
• Brachytherapy Improves Biochemical Failure–Free Survival in Low- and Intermediate-Risk Prostate Cancer Compared With Conventionally Fractionated External Beam Radiation Therapy: A Propensity Score Matched Analysis  Journal Articles
• Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter  Journal Articles
• Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers  Journal Articles
• Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level  Journal Articles
• Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.  Journal Articles
• Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy  Journal Articles
• Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection  Journal Articles
• Controversies in prostate cancer radiotherapy: consensus development.  Journal Articles
• Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity  Journal Articles
• Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis  Journal Articles
• DEVELOPMENT OF PROSTATE-SPECIFIC ANTIGEN PROMOTER-BASED GENE THERAPY FOR ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER  Journal Articles
• DNA cytometric proliferative index predicting organ confinement in clinical stage-B prostate cancer  Journal Articles
• Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT  Journal Articles
• Differences in total PSA results within and between manufacturers  Journal Articles
• Disease control outcomes of stereotactic body radiation therapy or moderate hypo‐fractionation for prostate cancer: Real‐world experience at two Canadian centers  Journal Articles
• Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study  Journal Articles
• Does early detection of prostate cancer offer more good than harm?  Journal Articles
• Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910  Journal Articles
• Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial  Journal Articles
• Dynamic Bio‐Barcode Assay Enables Electrochemical Detection of a Cancer Biomarker in Undiluted Human Plasma: A Sample‐In‐Answer‐Out Approach  Journal Articles
• Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary  Journal Articles
• Effect of ¹⁸F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial  Journal Articles
• Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer  Journal Articles
• Effects of chronic intermittent hypobaric hypoxia on prostate-specific antigen (PSA) in Chilean miners  Journal Articles
• Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: Implications for prior therapy in clinical trials  Journal Articles
• Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination  Journal Articles
• Enhancing Citizen Engagement in Cancer Screening Through Deliberative Democracy  Journal Articles
• Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer  Journal Articles
• Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer  Journal Articles
• Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions  Journal Articles
• Expression of the prostate-specific antigen gene by a primary ovarian carcinoma.  Journal Articles
• Frequency of Expression of Prostate-Specific Antigen mRNA in Lung Tumors  Journal Articles
• Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial  Journal Articles
• Guideline for referral of patients with suspected prostate cancer by family physicians and other primary care providers.  Journal Articles
• High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.  Conferences
• High-intensity Focused Ultrasound for Prostate Cancer: a Systematic Review  Journal Articles
• Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes.  Journal Articles
• Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators  Journal Articles
• Immunoreactive prostate‐specific antigen in lung tumors  Journal Articles
• Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio  Journal Articles
• Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy  Journal Articles
• Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate  Journal Articles
• Making Sense of Prostate Specific Antigen: Improving its Predictive Value in Patients Undergoing Prostate Biopsy  Journal Articles
• Management of a patient with locally advanced prostate cancer with degarelix: a case report  Journal Articles
• Misunderstandings, misperceptions, and mistakes  Journal Articles
• Molecular radiotheragnostics in prostate cancer  Journal Articles
• Neutropenia as a Potential Pharmacodynamic Marker for Docetaxel-Based Chemotherapy in Men With Metastatic Castration-Resistant Prostate Cancer  Journal Articles
• PREDICTORS OF PATHOLOGICAL STAGE BEFORE NEOADJUVANT ANDROGEN WITHDRAWAL THERAPY AND RADICAL PROSTATECTOMY  Journal Articles
• PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo  Journal Articles
• PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide  Journal Articles
• PSA implications and medical management of prostate cancer for the primary care physician.  Journal Articles
• Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.  Journal Articles
• Plasma osteopontin  Journal Articles
• Potential Value of Gleason Score in Predicting the Benefit of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer  Journal Articles
• Preparation and Evaluation of Radiolabeled Antibody Recruiting Small Molecules That Target Prostate-Specific Membrane Antigen for Combined Radiotherapy and Immunotherapy  Journal Articles
• Presence and enzymatic activity of prostate-specific antigen in archival prostate cancer samples  Journal Articles
• Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials  Journal Articles
• Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer  Journal Articles
• Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review  Journal Articles
• Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.  Journal Articles
• Prostate Cancer Radiotherapy: An Evolving Paradigm  Journal Articles
• Prostate cancer in young men: An emerging young adult and older adolescent challenge  Journal Articles
• Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline  Journal Articles
• Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis  Journal Articles
• Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue  Journal Articles
• Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials  Journal Articles
• Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance  Journal Articles
• Prostate-specific antigen in serum of women with breast cancer  Journal Articles
• Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.  Journal Articles
• Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician’s guide  Journal Articles
• Prostate‐Specific antigen expression by various tumors  Journal Articles
• Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer  Journal Articles
• Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response  Journal Articles
• Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer  Conferences
• Recommendations on screening for prostate cancer with the prostate-specific antigen test  Journal Articles
• Recommendations on secondary prevention of prostate cancer from the Canadian Task Force on the Periodic Health Examination.  Journal Articles
• Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration‐resistant prostate cancer treated with custirsen  Journal Articles
• Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer  Journal Articles
• Salvage radiotherapy following HiFU: An institutional series and literature review  Journal Articles
• Screening for prostate cancer: protocol for updating multiple systematic reviews to inform a Canadian Task Force on Preventive Health Care guideline update  Journal Articles
• Screening history and risk of death from prostate cancer: a nested case–control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)  Journal Articles
• Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy  Journal Articles
• Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials  Journal Articles
• Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone Acetate  Journal Articles
• Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data  Journal Articles
• Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa  Journal Articles
• Synthesis and Preclinical Evaluation of [¹⁸F]SiFA-PSMA Inhibitors in a Prostate Cancer Model  Journal Articles
• Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy  Journal Articles
• Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.  Journal Articles
• Systematic review of clinical features of suspected prostate cancer in primary care.  Journal Articles
• Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile  Journal Articles
• Testing the evolution process of prostate‐specific antigen in early stage prostate cancer: what is the proper underlying model?  Journal Articles
• The Effect of Vitamin D Supplementation on Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials  Journal Articles
• The Prostate Cancer Risk Stratification Project: Database Construction and Risk Stratification Outcome Analysis  Journal Articles
• The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial  Journal Articles
• The association between radiographic response and overall survival in men with metastatic castration‐resistant prostate cancer receiving chemotherapy  Journal Articles
• The importance of tumour marker dual reporting during method transition: PSA high-dose hook effect detected  Journal Articles
• The natural-killer-cell-associated HNK-1 (Leu-7) antibody reacts with hypertrophic and malignant prostatic epithelium  Journal Articles
• Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer  Journal Articles
• Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial  Journal Articles
• Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials  Journal Articles
• Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study  Journal Articles
• Use of machine learning to predict early biochemical recurrence after robot‐assisted prostatectomy  Journal Articles
• Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer  Journal Articles
• Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer  Journal Articles
• Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review  Journal Articles
• “PSA-itis”: Knowledge of Serum Prostate Specific Antigen and Other Causes of Anxiety in Men with Metastatic Prostate Cancer  Journal Articles